Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2025 Q1 2024 Q4, filed 15 May, long equity only

Download CSV Download Excel All activity


MSFT, Microsoft	4.78%, was 3.49%	Add +40.0%	2,285,835	$375.39	$858M	+652,688	+$170M
EXEL, Exelixis	4.64%	Reduce −3.9%	22,533,500	$36.92	$832M	−906,000	+$51M
UNH, UnitedHealth Group	4.37%, was 3.75%	Add +2.4%	1,497,900	$523.75	$785M	+35,400	+$45M
NTRA, Natera	3.59%, was 3.56%	Add +2.6%	4,547,809	$141.41	$643M	+116,200	−$58M
IQV, IQVIA	3.35%, was 3.11%	Add +9.2%	3,411,851	$176.30	$602M	+288,700	−$12M
LNTH, Lantheus	3.28%, was 2.41%	Add +13.3%	6,023,227	$97.60	$588M	+707,000	+$112M
ARMK, Aramark	3.13%, was 2.16%	Add +42.3%	16,241,996	$34.52	$561M	+4,831,656	+$135M
DIS, Disney	3.02%, was 2.50%	Add +24.1%	5,496,223	$98.70	$542M	+1,068,155	+$49M
CRM, Salesforce	2.94%, was 2.05%	Add +62.6%	1,967,110	$268.36	$528M	+756,972	+$123M
ADSK, Autodesk	2.92%, was 2.76%	Add +8.4%	1,997,400	$261.80	$523M	+155,600	−$21M
INTU, Intuit	2.88%, was 2.40%	Add +11.5%	840,258	$613.99	$516M	+86,500	+$42M
TMO, Thermo Fisher Scientific	2.87%, was 3.25%	Reduce −16.0%	1,035,856	$497.60	$515M	−197,400	−$126M
RVMD, Revolution Medicines	2.67%	Add +2.2%	13,534,692	$35.36	$479M	+286,000	−$101M
TRU, Transunion	2.50%	Add +1.6%	5,413,206	$82.99	$449M	+86,887	−$45M
NYT, New York Times	2.47%, was 1.95%	Add +21.1%	8,932,113	$49.60	$443M	+1,556,000	+$59M
Intra-Cellular Therapies	2.25%	New	3,055,000	$131.92	$403M	+3,055,000	+$403M
BSX, Boston Scientific	2.12%, was 2.28%	Reduce −25.1%	3,762,757	$100.88	$380M	−1,260,200	−$69M
AON, Aon	2.11%, was 3.34%	Reduce −25.7%	1,361,744	$277.83	$378M	−470,989	−$280M
MCK, McKesson	2.07%	Reduce −9.5%	552,500	$672.99	$372M	−58,200	+$24M
NDAQ, Nasdaq	1.89%, was 1.57%	Add +11.6%	4,460,288	$75.86	$338M	+462,269	+$29M
CBRE, CBRE Group	1.82%, was 1.45%	Add +14.5%	2,495,700	$130.78	$326M	+315,900	+$40M
SCHW, Charles Schwab	1.67%, was 1.19%	Add +20.9%	3,832,857	$78.28	$300M	+663,857	+$65M
PTGX, Protagonist Therapeutics	1.65%, was 1.16%	Add +3.0%	6,107,006	$48.36	$295M	+177,000	+$66M
WAB, Wabtec	1.63%, was 1.38%	Add +12.4%	1,608,098	$181.35	$292M	+177,900	+$20M
GBTC, iShares Bitcoin Trust ETF	1.51%, was 1.95%	Reduce −20.2%	5,793,800	$46.81	$271M	−1,465,300	−$114M
ADI, Analog Devices	1.49%, was 1.25%	Add +14.7%	1,327,000	$201.67	$268M	+169,800	+$22M
GOOG, Alphabet	1.45%, was 2.01%	Reduce −19.9%	1,666,040	$156.23	$260M	−414,500	−$136M
WWD, Woodward	1.44%	Reduce −6.7%	1,419,700	$182.49	$259M	−101,600	+$5.9M
HIMS, Hims & Hers Health	1.31%	Reduce −5.1%	7,953,705	$29.55	$235M	−423,295	+$32M
BBIO, Bridgebio	1.10%, was 0.58%	Add +36.6%	5,731,000	$34.57	$198M	+1,536,000	+$83M
BEAM, Beam Therapeutics	1.08%, was 1.04%	Add +20.5%	9,928,111	$19.53	$194M	+1,688,988	−$10M
AGIO, Agios Pharmaceuticals	0.93%	Add +0.5%	5,700,466	$29.30	$167M	+26,000	−$19M
V, Visa	0.93%	Reduce −13.7%	474,210	$350.46	$166M	−75,300	−$7.5M
CRNX	0.86%	Add +13.0%	4,605,098	$33.54	$154M	+530,000	−$54M
Sarepta Therapeutics	0.83%, was 1.77%	Reduce −18.3%	2,341,424	$63.82	$149M	−523,676	−$199M
BHVN, Biohaven	0.65%	Add +8.7%	4,813,167	$24.04	$116M	+385,000	−$50M
MA, Mastercard	0.62%, was 0.79%	Reduce −31.9%	201,371	$548.12	$110M	−94,300	−$45M
YMM, Full Truck Alliance	0.52%, was 0.91%	Reduce −55.6%	7,357,207	$12.77	$94M	−9,227,888	−$85M
SGI, Somnigroup International	0.44%	New	1,326,242	$59.88	$79M	+1,326,242	+$79M
WAY, Waystar	0.42%, was 0.25%	Add +50.5%	2,020,000	$37.36	$75M	+678,000	+$26M
Holding	0.38%	New	1,084,989	$63.49	$69M	+1,084,989	+$69M
EHC, Encompass Health	0.35%, was 0.22%	Add +34.3%	619,000	$101.28	$63M	+158,000	+$20M
EDU	0.35%, was 0.77%	Reduce −44.7%	1,305,150	$47.81	$62M	−1,054,000	−$89M
CNTA, Centessa Pharmaceuticals	0.35%, was 0.30%	Add +23.9%	4,334,318	$14.38	$62M	+835,609	+$3.7M
LQDA, Liquidia	0.33%, was 0.20%	Add +21.3%	3,990,956	$14.75	$59M	+700,000	+$20M
FLUT, Flutter Entertainment	0.30%, was 0.12%	Add +167.4%	241,467	$221.55	$53M	+151,167	+$30M
ALKS, Alkermes	0.26%	New	1,389,800	$33.02	$46M	+1,389,800	+$46M
ABT, Abbott Laboratories	0.25%	New	333,000	$132.65	$44M	+333,000	+$44M
GEHC, GE HealthCare	0.24%, was 0.05%	Add +333.1%	537,000	$80.71	$43M	+413,000	+$34M
BBNX, Beta Bionics	0.23%	New	3,332,220	$12.24	$41M	+3,332,220	+$41M
CAH, Cardinal Health	0.21%	New	273,000	$137.77	$38M	+273,000	+$38M
HQY, Healthequity	0.21%	Add +14964.3%	421,800	$88.37	$37M	+419,000	+$37M
JOYY	0.18%	New	780,000	$41.98	$33M	+780,000	+$33M
WGS, Genedx	0.15%, was 0.08%	Add +55.4%	303,000	$88.56	$27M	+108,000	+$12M
CAPR	0.12%	Hold	2,250,400	$9.49	$21M	—	—
VNET, Vnet Group	0.11%, was 0.02%	Add +275.2%	2,439,120	$8.20	$20M	+1,789,120	+$17M
Savara	0.11%	Hold	6,835,000	$2.77	$19M	—	—
Latam Airlines Group	0.10%	Reduce −9.1%	562,010	$31.28	$18M	−56,459	+$522K
TECX, Tectonic Therapeutic	0.08%	Add +19.6%	853,050	$17.71	$15M	+140,000	−$18M
ENTA, Enanta Pharmaceuticals	0.07%, was 0.06%	Add +0.7%	2,122,262	$5.52	$12M	+14,000	−$408K
NUVL, Nuvalent	0.06%	Hold	150,000	$70.92	$11M	—	—
TYRA, Tyra Biosciences	0.06%	Add +14.3%	1,143,818	$9.30	$11M	+142,837	−$3.3M
Mara	0.05%	Add +50.5%	835,000	$11.50	$9.6M	+280,000	+$295K
VYGR, Voyager Therapeutics	0.05%	Hold	2,570,700	$3.38	$8.7M	—	—
Helix Acquisition Corporation II	0.04%	Hold	600,000	$11.30	$6.8M	—	—
TNGX, Tango Therapeutics	0.04%	Add +15.3%	4,610,930	$1.37	$6.3M	+610,930	−$6M
GMED, Globus Medical	0.03%	Add +2205.6%	83,000	$73.20	$6.1M	+79,400	+$5.8M
Springworks Therapeutics	0.03%	New	118,000	$44.13	$5.2M	+118,000	+$5.2M
Zymeworks	0.03%, was 0.10%	Reduce −69.9%	400,000	$11.91	$4.8M	−929,974	−$15M
Rxsight	0.02%	New	175,000	$25.25	$4.4M	+175,000	+$4.4M
Verve Therapeutics	0.02%	New	912,000	$4.57	$4.2M	+912,000	+$4.2M
SMC, Summit Midstream	0.01%	Hold	58,214	$33.89	$2M	—	—
ALVO, Alvotech	0.01%	Hold	199,675	$9.67	$1.9M	—	—
Marblegate Acquisition	0.01%	Hold	150,000	$11.05	$1.7M	—	—
PRME, Prime Medicine	0.01%	Hold	750,000	$1.99	$1.5M	—	—
SIMO, Silicon Motion Technology	0.01%, was 0.11%	Reduce −92.9%	29,298	$50.56	$1.5M	−385,702	−$21M
LIVN, Livanova	0.01%	New	37,000	$39.28	$1.5M	+37,000	+$1.5M
Janux Therapeutics	0.01%	Hold	48,000	$27.00	$1.3M	—	—
Biodesix	0.01%, was 0.03%	Reduce −51.2%	1,859,308	$0.6252	$1.2M	−1,952,118	−$4.7M
MDGL, Madrigal Pharmaceuticals	0.01%	Hold	3,319	$331.23	$1.1M	—	—
Cara Therapeutics	0.00%	Hold	129,685	$5.07	$658K	—	—
Forte Biosciences	0.00%	Add +101.2%	70,429	$7.76	$547K	+35,429	−$248K
AXSM, Axsome Therapeutics	0.00%	Hold	4,000	$116.63	$467K	—	—
ARQT, Arcutis Biotherapeutics	0.00%	Hold	26,000	$15.64	$407K	—	—
PGNY, Progyny	0.00%	Hold	18,000	$22.34	$402K	—	—
BTSG, Brightspring Health Services	0.00%	Hold	22,000	$18.09	$398K	—	—
ROIV, Roivant Sciences	0.00%	Hold	37,000	$10.09	$373K	—	—
KRYS, Krystal Biotech	0.00%	Hold	2,000	$180.30	$361K	—	—
SLNO, Soleno Therapeutics	0.00%, was 0.02%	Reduce −94.4%	5,000	$71.45	$357K	−85,000	−$3.7M
Blueprint Medicines	0.00%	Hold	4,000	$88.51	$354K	—	—
Sage Therapeutics	0.00%	Hold	42,800	$7.95	$340K	—	—
MMSI, Merit Medical Systems	0.00%	Hold	3,000	$105.71	$317K	—	—
UTHR, United Therapeutics	0.00%	Hold	1,000	$308.27	$308K	—	—
TWST, Twist Bioscience	0.00%	Hold	7,650	$39.26	$300K	—	—
ONC, Beigene	0.00%	Hold	1,100	$272.17	$299K	—	—
COR, Cencora	0.00%	Hold	1,000	$278.09	$278K	—	—
ACLX, Arcellx	0.00%	Hold	4,000	$65.60	$262K	—	—
GKOS, Glaukos	0.00%	Hold	2,600	$98.42	$256K	—	—
CHE, Chemed	0.00%	Hold	400	$615.32	$246K	—	—
SBRA, Sabra Health Care REIT	0.00%	Hold	14,000	$17.47	$245K	—	—
INSM, Insmed	0.00%	Hold	3,000	$76.29	$229K	—	—
SRRK, Scholar Rock	0.00%	Hold	7,000	$32.15	$225K	—	—
BRKR, Bruker	0.00%	Hold	5,000	$41.74	$209K	—	—
IMVT, Immunovant	0.00%	Hold	12,000	$17.09	$205K	—	—
HR, Healthcare Realty Trust	0.00%, was 0.28%	Reduce −99.6%	12,000	$16.90	$203K	−3,252,000	−$55M
ARWR, Arrowhead Pharmaceuticals	0.00%, was 0.06%	Reduce −97.5%	15,800	$12.74	$201K	−613,000	−$12M
GRFS, Grifols	0.00%	Hold	28,000	$7.11	$199K	—	—
ELAN, Elanco Animal Health	0.00%	Hold	16,000	$10.50	$168K	—	—
PACB	0.00%	Hold	135,000	$1.18	$159K	—	—
OSCR, Oscar Health	0.00%	Hold	11,000	$13.11	$144K	—	—
ALT, Altimmune	0.00%	Hold	27,600	$5.00	$138K	—	—
EVH, Evolent Health	0.00%	Hold	14,000	$9.47	$133K	—	—
FOLD, Amicus	0.00%	Hold	16,000	$8.16	$131K	—	—
SNDX, Syndax Pharmaceuticals	0.00%	Hold	10,000	$12.28	$123K	—	—
ARDX, Ardelyx	0.00%	Hold	23,000	$4.91	$113K	—	—
DYN, Dyne Therapeutics	0.00%, was 0.03%	Reduce −95.6%	10,000	$10.46	$105K	−219,121	−$5.3M
NVAX, Novavax	0.00%	Hold	16,000	$6.41	$103K	—	—
COGT, Cogent Biosciences	0.00%	Hold	17,000	$5.99	$102K	—	—
IOVA, Iovance Biotherapeutics	0.00%	Hold	26,000	$3.33	$87K	—	—
GERN, Geron	0.00%	Hold	43,000	$1.59	$68K	—	—
CCCC, C4 Therapeutics	0.00%	Hold	28,000	$1.60	$45K	—	—
ANNA, Aleanna	0.00%	Hold	78,400	$0.4465	$35K	—	—
CGC, Canopy Growth	0.00%	Hold	30,000	$0.9100	$27K	—	—
IRWD, Ironwood Pharmaceuticals	0.00%	Hold	13,000	$1.47	$19K	—	—

Showing top 50 of 124 by value

Exits / last held

Gone since 2024 Q4, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
ABNB, Airbnb	1.62%	Exit	$131.41	$319M	−2,429,200	−$319M
BMY, Bristol Myers Squibb	0.91%	Exit	$56.56	$180M	−3,188,000	−$180M
Masimo	0.33%	Exit	$165.30	$66M	−397,000	−$66M
SPY, SPDR S&P 500 ETF Trust	0.24%	Exit	$586.09	$48M	−82,000	−$48M
GDS, GDS Holdings	0.18%	Exit	$23.76	$36M	−1,531,133	−$36M
GXO, Gxo Logistics	0.11%	Exit	$43.50	$22M	−513,400	−$22M
Mac Copper	0.02%	Exit	$10.62	$3.5M	−330,901	−$3.5M
Elevation Oncology	0.01%	Exit	$0.5627	$2M	−3,527,482	−$2M
HCA, HCA Healthcare	—	Exit	$300.00	$300K	−1,000	−$300K
EW, Edwards Lifesciences	—	Exit	$74.00	$222K	−3,000	−$222K
ICU Medical	—	Exit	$155.00	$217K	−1,400	−$217K
ICLR, Icon	—	Exit	$210.00	$210K	−1,000	−$210K
Beyond Meat	—	Exit	$3.74	$71K	−19,000	−$71K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov